Literature DB >> 21451995

Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis.

Aldina Reis1, Catarina Mateus, M Carmo Macário, José R Faria de Abreu, Miguel Castelo-Branco.   

Abstract

Asymptomatic visual loss is a feature of multiple sclerosis (MS) but its relative impact on distinct retinocortical pathways is still unclear. The goal of this work was to investigate patterns of subclinical visual impairment in patients with MS with and without clinically associated previous optic neuritis (ON). We have used functional methods that assess parvo-, konio- and magnocellular pathways in order to compare pathophysiological mechanisms of damage in a population of 44 subjects with MS (87 eyes), with and without a previous episode of ON. These methods included chromatic contrast sensitivity across multiple chromatic axes (Cambridge Colour Test-parvo/konio pathways), perimetric achromatic contrast sensitivity for the magno pathway [frequency doubling technique (FDT)] and pattern visual evoked potentials (VEP). These measures were correlated with field sensitivity measures obtained using conventional automated static perimetry (ASP) and were also compared with conventional clinical chromatic/achromatic contrast sensitivity chart-based measures. We have found evidence for uncorrelated damage of all retinocortical pathways only in patients with MS without ON. VEP evidence for axonal damage was found in this group supporting the emerging notion of axonal damage even in sub-clinical stages of ON/MS pathophysiology. Only in this group was significant correlation of functional measures with disease stage observed, suggesting that distinct pathophysiological milestones are present before and after ON has occurred.

Entities:  

Mesh:

Year:  2011        PMID: 21451995     DOI: 10.1007/s00415-011-6008-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  31 in total

1.  Comparison between Tendency-Oriented Perimetry (TOP) and octopus threshold perimetry.

Authors:  J Morales; M L Weitzman; M González de la Rosa
Journal:  Ophthalmology       Date:  2000-01       Impact factor: 12.079

2.  Serial visual evoked potentials in 90 untreated patients with acute optic neuritis.

Authors:  J L Frederiksen; J Petrera
Journal:  Surv Ophthalmol       Date:  1999-10       Impact factor: 6.048

3.  Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis.

Authors:  D Travis; P Thompson
Journal:  Brain       Date:  1989-04       Impact factor: 13.501

4.  Quantitative phenotyping of chromatic dysfunction in best macular dystrophy.

Authors:  Sónia H Campos; Vasco Forjaz; Lajos R Kozak; Eduardo Silva; Miguel Castelo-Branco
Journal:  Arch Ophthalmol       Date:  2005-07

5.  Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.

Authors:  M F Silva; P Faria; F S Regateiro; V Forjaz; C Januário; A Freire; M Castelo-Branco
Journal:  Brain       Date:  2005-07-06       Impact factor: 13.501

6.  The prognosis of idiopathic optic neuritis.

Authors:  A Ghezzi; V Martinelli; M Rodegher; M Zaffaroni; G Comi
Journal:  Neurol Sci       Date:  2000       Impact factor: 3.307

7.  Optimization of stimuli for trit-anomaloscopy.

Authors:  J D Moreland; J Kerr
Journal:  Mod Probl Ophthalmol       Date:  1978

8.  Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis.

Authors:  V Porciatti; F Sartucci
Journal:  Brain       Date:  1996-06       Impact factor: 13.501

9.  Colour and luminance vision in human optic neuritis.

Authors:  K T Mullen; G T Plant
Journal:  Brain       Date:  1986-02       Impact factor: 13.501

10.  Colour vision abnormalities in multiple sclerosis.

Authors:  A C Harrison; W J Becker; W K Stell
Journal:  Can J Neurol Sci       Date:  1987-08       Impact factor: 2.104

View more
  6 in total

1.  Early visual cortical structural changes in diabetic patients without diabetic retinopathy.

Authors:  Fábio S Ferreira; João M S Pereira; Aldina Reis; Mafalda Sanches; João V Duarte; Leonor Gomes; Carolina Moreno; Miguel Castelo-Branco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-04       Impact factor: 3.117

2.  Progress in multiple sclerosis research in the last year.

Authors:  Daniela Galimberti; Elio Scarpini
Journal:  J Neurol       Date:  2012-06-22       Impact factor: 4.849

3.  Comparison of Visual Field Parameters in Early and Advanced Stages of Multiple Sclerosis Patients Without a History of Optic Neuritis.

Authors:  Mete Güler; Peykan Türkçüoğlu; Turgut Yılmaz; Tahir Kurtuluş Yoldaş; Roomasa Channa
Journal:  Neuroophthalmology       Date:  2013-03-22

4.  Physiological evidence for impairment in autosomal dominant optic atrophy at the pre-ganglion level.

Authors:  Aldina Reis; Catarina Mateus; Teresa Viegas; Ralph Florijn; Arthur Bergen; Eduardo Silva; Miguel Castelo-Branco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-04       Impact factor: 3.117

5.  Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun; Oguzhan Oz; Uzeyir Erdem; Gungor Sobaci
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

6.  Aging of low and high level vision: from chromatic and achromatic contrast sensitivity to local and 3D object motion perception.

Authors:  Catarina Mateus; Raquel Lemos; Maria Fátima Silva; Aldina Reis; Pedro Fonseca; Bárbara Oliveiros; Miguel Castelo-Branco
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.